Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Di Leo

Showing results (1-10 of 223) with videos related to

Pageof 23
Sort By:
World Journal of Gastroenterology|July 16, 2014
HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogue therapyMichele Barone, Andrea Iannone, Alfredo Di Leo
Gastroenterology|May 28, 2021
Helicobacter pylori Antibiotic Resistance: Stewardship, Tailored Therapies, and Future PerspectivesGiuseppe Losurdo, Enzo Ierardi, Alfredo Di Leo
Gastroenterology|December 30, 2019
What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors?Giuseppe Losurdo, Alfredo Di Leo, Gioacchino Leandro
Virchows Archiv : an International Journal of Pathology|June 20, 2018
Novel steps forward in the histopathology of non-celiac gluten sensitivityGiuseppe Losurdo, Domenico Piscitelli, Alfredo Di Leo
Gastroenterology|August 31, 2015
Machine Learning Methods in GastroenterologyAntonio Facciorusso, Raffaele Licinio, Alfredo Di Leo
Nutrition and Metabolic Insights|June 18, 2019
Can the Antisecretory Factor Be Considered a New Therapy for the Short Bowel Syndrome?Maria Teresa Viggiani, Alfredo Di Leo, Michele Barone
Expert Review of Gastroenterology & Hepatology|June 9, 2020
Might helicobacter pylori play a role in allergic or cross-reaction related disorders?Enzo Ierardi, Giuseppe Losurdo, Floriana Giorgio, et al.
The American Journal of Gastroenterology|May 6, 2015
Combination therapy with sorafenib and radiofrequency ablation for hepatocellular carcinoma: a glimmer of light after the storm trial?Antonio Facciorusso, Nicola Muscatiello, Alfredo Di Leo, et al.
Medical Oncology (Northwood, London, England)|July 24, 2020
The perplexity of targeting genetic alterations in hepatocellular carcinomaMichele Barone, Alfredo Di Leo, Carlo Sabbà, et al.
World Journal of Hepatology|October 3, 2014
Liver fibrosis in primary intestinal lymphangiectasia: An undervalued topicRaffaele Licinio, Mariabeatrice Principi, Enzo Ierardi, et al.
Pageof 23

Showing results (1-10 of 223) with videos related to

Sort By:
Pageof 23
World Journal of Gastroenterology|July 16, 2014
HBsAg clearance by Peg-interferon addition to a long-term nucleos(t)ide analogue therapyMichele Barone, Andrea Iannone, Alfredo Di Leo
Gastroenterology|May 28, 2021
Helicobacter pylori Antibiotic Resistance: Stewardship, Tailored Therapies, and Future PerspectivesGiuseppe Losurdo, Enzo Ierardi, Alfredo Di Leo
Gastroenterology|December 30, 2019
What Is the Optimal Follow-up Time to Ascertain the Safety of Proton Pump Inhibitors?Giuseppe Losurdo, Alfredo Di Leo, Gioacchino Leandro
Virchows Archiv : an International Journal of Pathology|June 20, 2018
Novel steps forward in the histopathology of non-celiac gluten sensitivityGiuseppe Losurdo, Domenico Piscitelli, Alfredo Di Leo
Gastroenterology|August 31, 2015
Machine Learning Methods in GastroenterologyAntonio Facciorusso, Raffaele Licinio, Alfredo Di Leo
Nutrition and Metabolic Insights|June 18, 2019
Can the Antisecretory Factor Be Considered a New Therapy for the Short Bowel Syndrome?Maria Teresa Viggiani, Alfredo Di Leo, Michele Barone
Expert Review of Gastroenterology & Hepatology|June 9, 2020
Might helicobacter pylori play a role in allergic or cross-reaction related disorders?Enzo Ierardi, Giuseppe Losurdo, Floriana Giorgio, et al.
The American Journal of Gastroenterology|May 6, 2015
Combination therapy with sorafenib and radiofrequency ablation for hepatocellular carcinoma: a glimmer of light after the storm trial?Antonio Facciorusso, Nicola Muscatiello, Alfredo Di Leo, et al.
Medical Oncology (Northwood, London, England)|July 24, 2020
The perplexity of targeting genetic alterations in hepatocellular carcinomaMichele Barone, Alfredo Di Leo, Carlo Sabbà, et al.
World Journal of Hepatology|October 3, 2014
Liver fibrosis in primary intestinal lymphangiectasia: An undervalued topicRaffaele Licinio, Mariabeatrice Principi, Enzo Ierardi, et al.
Pageof 23